Patents by Inventor Karin Lauer

Karin Lauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9844515
    Abstract: The invention is concerned with a transdermal therapeutic system (TTS) comprising buprenorphine and a method of manufacturing such a TTS. The transdermal therapeutic system is used for the transdermal administration of buprenorphine and analogues thereof. In particular, the invention relates to the use of a transdermal therapeutic system (TTS) for analgesic purposes. The TTS according to the invention comprises a transdermal drug delivery composition comprising buprenorphine and an adhesive component, which is a mixture of a crosslinked and a non-crosslinked acrylic polymer and a penetration enhancer comprising a keto acid.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: December 19, 2017
    Assignee: Hexal AG
    Inventors: Jens Fleschhut, Susanne Feinaeugle, Karin Lauer
  • Publication number: 20130331803
    Abstract: The invention is concerned with a transdermal therapeutic system (TTS) comprising buprenorphine and a method of manufacturing such a TTS. The transdermal therapeutic system is used for the transdermal administration of buprenorphine and analogues thereof. In particular, the invention relates to the use of a transdermal therapeutic system (TTS) for analgesic purposes. The TTS according to the invention comprises a transdermal drug delivery composition comprising buprenorphine and an adhesive component, which is a mixture of a crosslinked and a non-crosslinked acrylic polymer and a penetration enhancer comprising a keto acid.
    Type: Application
    Filed: November 17, 2010
    Publication date: December 12, 2013
    Applicant: HEXAL AG
    Inventors: Jens Fleschhut, Susanne Feinaeugle, Karin Lauer
  • Publication number: 20060246041
    Abstract: The present invention makes available an optimal concentration of a hedgehog polypeptide for modulating growth and/or cartilage production by chondrocytes. The present invention allows for improvements in the culturing of chondrocytes to develop cartilaginous tissue ex vivo suitable for implantation to replace damaged or deteriorated cartilage in a patient.
    Type: Application
    Filed: April 3, 2006
    Publication date: November 2, 2006
    Inventors: Karin Lauer, Kurt Lang, Apollon Papadimitriou, Ulrike Reiff, Michaela Schulz, Torsten Blunk, Achim Goepferich